President Donald Trump’s (R) preliminary budget appears to call for “new authority to regulate all aspects of the 340B program,” [...] …
Category: General
Tariffs on Pharmaceuticals Could Worsen Drug Shortages, Cause Disarray in 340B Prices, Advocates Say
President Donald Trump’s (R) plan to place tariffs on foreign pharmaceuticals could destabilize 340B drugs’ prices unless drugmakers absorb the [...] …
The U.S. Department of Health and Human Services (HHS) should identify and implement ways to formally coordinate activities relating to [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
U.S. Department of Health and Human Services (HHS) officials last week briefed the Republican and Democratic staff of a key [...] …
Johnson & Johnson (J&J) added Ustekinumab, the unbranded version of psoriatic arthritis treatment Stelara, to its 340B contract pharmacy restrictions [...] …
The Trump administration’s recent efforts to restructure the Department of Health and Human Services (HHS)—including division consolidations and the elimination [...] …
The U.S. Senate voted along party lines Thursday to confirm Mehmet Oz—a celebrity heart surgeon known as “Dr. Oz” for [...] …
The leaders of a Senate panel that oversees several key federal health agencies this week invited Health and Human Services [...] …
Three drugmakers that have sued the federal government to convert 340B discounts to a rebate model, and a drug industry [...] …